AMP nasal provocation elicits mast cell degranulation: inhibition by topical heparin

D. Zeng, G. Prosperini, C. Russo, L. Spicuzza, R. Cacciola, G. Di Maria, R. Polosa (Palo Alto, United States Of America; Catania, Italy)

Source: Annual Congress 2004 - Allergic asthma, bronchial hyperreactivity and related airway disease
Session: Allergic asthma, bronchial hyperreactivity and related airway disease
Session type: Thematic Poster Session
Number: 3622
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Zeng, G. Prosperini, C. Russo, L. Spicuzza, R. Cacciola, G. Di Maria, R. Polosa (Palo Alto, United States Of America; Catania, Italy). AMP nasal provocation elicits mast cell degranulation: inhibition by topical heparin. Eur Respir J 2004; 24: Suppl. 48, 3622

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Salbutamol attenuates nasal symptoms and mast cell degranulation by AMP challenge
Source: Eur Respir J 2005; 26: Suppl. 49, 228s
Year: 2005

Oral presentation: Sphingosine-1-phosphate administration in vivo induces airway inflammation and hypereactivity in a IgE-dependent manner
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013


Lack of evidence for mast cell activation following positive inhaled adenosine challenge
Source: Eur Respir J 2005; 26: Suppl. 49, 229s
Year: 2005

Sodium cromoglycate inhibits release of mast cell mediators and bronchoconstriction following hyperpnea in athletes
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010

Effect of airway provocation with histamine and adenosine 5’-monophosphate on sputum neutrophils and -related mediators
Source: Eur Respir J 2004; 24: Suppl. 48, 442s
Year: 2004

Chlorine inhalation produces nasal congestion in allergic rhinitics without mast cell degranulation
Source: Eur Respir J 2003; 21: 652-657
Year: 2003



Enhancement of eosinophil apoptosis by antihistamines
Source: Eur Respir J 2004; 24: Suppl. 48, 354s
Year: 2004

Mast cell mediator release during refractoriness to mannitol-induced bronchoconstriction
Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Year: 2009

LSC 2011 Abstract: Combined nasal exposure to sodium hypochlorite and ovalbumin induces airway hyperreactivity in mice through activation of the TRPA1 channel and mast cells
Source: Annual Congress 2011 - Environmental exposure and disease mechanisms
Year: 2011


Mast cell degranulation in vivo is associated with amp airways responsiveness in atopic subjects
Source: Eur Respir J 2004; 24: Suppl. 48, 590s
Year: 2004

Concentration of a plasma component, that decreases sensitivity of basophils in a basophil activation test, increases during subcutaneous immunotherapy
Source: Annual Congress 2008 - Understanding airway inflammation
Year: 2008

Kinetics of cell infiltration in human and experimental asthma after allergen provocation
Source: Eur Respir J 2006; 28: Suppl. 50, 300s
Year: 2006

Hypertonic saline increases secretory and exudative responsiveness of human nasal airway in vivo
Source: Eur Respir J 2003; 21: 308-312
Year: 2003



Effects of glucocorticosteroids and antimicrobial drugs on inhibition of IL-1β- and PDBu-induced IL-8 release in the presence of pyocyanin in bronchial epithelial cell line
Source: Eur Respir J 2005; 26: Suppl. 49, 99s
Year: 2005

Synergistic inhibition of salmeterol with fluticasone propionate or rolipram on stimulated eosinophil binding of β2-integrin to ICAM-1 and cytosolic gIV-phospholipase A2 activation
Source: Eur Respir J 2003; 22: Suppl. 45, 455s
Year: 2003

Budesonide and formoterol inhibit bronchial epithelial cell-mediated eosinophil superoxide production
Source: Eur Respir J 2005; 26: Suppl. 49, 123s
Year: 2005

Low doses of inhaled fluticasone propionate induce sputum eosinophil apoptosis and inhibit IL-5 release in naive symptomatic asthmatics (FLIC19)
Source: Eur Respir J 2001; 18: Suppl. 33, 336s
Year: 2001

Combined treatment with fluticasone plus salmeterol protects against allergen induced asthmatic responses and subsequent increase in sputum eosinophils
Source: Eur Respir J 2002; 20: Suppl. 38, 189s
Year: 2002